APA (7th ed.) Citation

K, H., T, K., T, E., A, T., Y, S., R, M., . . . S, O. (2025). Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study. Liver cancer. https://doi.org/10.1159/000549979

Chicago Style (17th ed.) Citation

K, Hashimoto, et al. "Atezolizumab Plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) Versus Atezolizumab Plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study." Liver Cancer 2025. https://doi.org/10.1159/000549979.

MLA (9th ed.) Citation

K, Hashimoto, et al. "Atezolizumab Plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) Versus Atezolizumab Plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study." Liver Cancer, 2025, https://doi.org/10.1159/000549979.